EX-FILING FEES 8 ea023945401ex-fee_silo.htm FILING FEE TABLE

Exhibit 107

 

Calculation of Filing Fee Tables

S-1
(Form Type)

 

SILO PHARMA, INC.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered and Carry Forward Securities

 

Title of each Class of Securities To be Registered  Amount to be
registered
(1)
   Proposed
maximum
Offering price
per share (2)
(3)(4)
   Proposed
maximum
aggregate
Offering price (1)(2)
   Amount of
registration
fee (3)
 
Common Stock, $0.0001 par value per share, to be offered by the issuer (4)                $               $5,000,000   $765.50 
Series A-1 Warrants to purchase Common Stock, $0.0001 par value per share (4)                   
Series A-2 Warrants to purchase Common Stock, $0.0001 par value per share (4)                   
Pre-funded warrants to purchase shares of Common Stock, par value $0.0001 per share (4)(5)                   
Warrants, issuable to the Placement Agent, to purchase shares of Common Stock, par value $0.001 per share (4)                   
Shares of Common Stock, $0.0001 par value underlying the Series A-1 Warrants (6)            $5,000,000    765.50 
Shares of Common Stock, $0.0001 par value underlying the Series A-2 Warrants (6)            $5,000,000    765.50 
Shares of Common Stock, par value $0.0001 per share underlying the Pre-funded warrants (4)(5)                   
Common Stock, par value $0.0001 per share issuable upon exercise of the Placement Agent Warrants (7)                $            $468,750   $71.77 
                     
Total           $15,468,750   $2,368.27 
                     
Registration Fee Previously Paid                 $-- 
Registration Fee Paid Herewith                 $2,368.27 

 

(1) Estimated solely for the purpose of computing the amount of the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”).
   
(2) Pursuant to Rule 416, the securities being registered hereunder include such indeterminate number of additional securities as may be issuable to prevent dilution resulting from stock splits, stock dividends or similar transactions.
   
(3) Calculated under Section 6(b) of the Securities Act as .0001531 times the proposed maximum aggregate offering price.
   
(4) No additional registration fee is payable pursuant to Rule 457(g) or Rule 457(i) under the Securities Act.
   
(5) The proposed maximum aggregate offering price of the Common Stock will be reduced on a dollar-for-dollar basis based on the offering price of any pre-funded warrants issued in the offering, and the proposed maximum aggregate offering price of the pre-funded warrants to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any common stock issued in the offering. Accordingly, the proposed maximum aggregate offering price of the common stock and pre-funded warrants (including the common stock issuable upon exercise of the pre-funded warrants), if any, is $5,000,000.
   
(6) The warrants are exercisable at a price per share of common stock equal to 100% of the offering price
   
(7) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under the Securities Act. The Placement Agent Warrants are exercisable for up to the number of shares of common stock equal to 7.5% of the shares of common stock sold in this offering (including the shares of common stock issuable upon the exercise of the pre-funded warrants sold in this offering) at a per share exercise price equal to 125% of the public offering price of the shares of common stock offered hereby. As estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under the Securities Act, the proposed maximum aggregate offering price of the representative’s warrants is $468,750, which is equal to 125% of $375,000 (7.5% of the proposed maximum aggregate offering price of $5,000,000).